Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8084978 | 0.87 | LMNA (0.41) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL16158023 | 0.79 | GAA (0.39) | TSHRNPC1CA12CA1CA2 | |
| SCHEMBL18826201 | 0.77 | LMNA (0.38) | TSHRCYP1A2CYP2D6NPC1CA12 | |
| SCHEMBL11121933 | 0.77 | TSHR (0.42) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10692851 | 0.73 | LTA4H (0.46) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL30605677 | 0.73 | LTA4H (0.46) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL4389326 | 0.73 | TSHR (0.33) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL198495 | 0.72 | TSHR (0.46) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11840842 | 0.72 | TSHR (0.46) | LTA4HTSHRCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL28285843 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014170681-A9 | OLIGOSACCHARIDE CONJUGATES AND METHODS OF USE | THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS (GB) | 2015-01-15 | — | — | WO | disclosed |
| US-8193366-B2 | Cyanine compounds | ADEKA CORPORATION (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20100204474-A1 | CYANINE COMPOUNDS | ADEKA CORPORATION (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7745632-B2 | Cyanine compounds, optical filters, and optical recording materials | ADEKA CORPORATION (JP) | 2010-06-29 | — | — | US | disclosed |
| US-20080207918-A1 | Cyanine Compounds, Optical Filters, and Optical Recording Materials | ADEKA CORPORATION (JP) | 2008-08-28 | — | — | US | disclosed |
| EP-1867682-A1 | CYANINE COMPOUNDS, OPTICAL FILTERS AND OPTICAL RECORDING MATERIALS | Adeka Corporation (JP) | 2007-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207918-A1 | Cyanine Compounds, Optical Filters, and Optical Recording Materials | KCNQ4, KCNQ3, KCNQ1 | LTA4H 3652/4885TSHR 3980/4885CYP1A2 153/4885 |
| US-20100204474-A1 | CYANINE COMPOUNDS | CYB5R3, KCNQ4, YBX1 | LTA4H 4535/4885TSHR 3976/4885CYP1A2 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.